Archives
-
CUDC-907 Dual PI3K and HDAC Workflow
2026-09-13
CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, histone acetylation, cell-cycle behavior, and apoptosis in cancer cell models. This guide covers preparation, assay setup, and quality control; the compound is for scientific research only and is not validated for diagnostic, therapeutic, or clinical use.
-
Berbamine hydrochloride in Ferroptosis Research
2026-09-12
Build a controlled workflow for studying Berbamine hydrochloride across NF-κB, STAT3, calcium, and ferroptosis-related readouts in cancer models. The approach separates established product characteristics from exploratory testing of the METTL16-SENP3-LTF axis in hepatocellular carcinoma.
-
Neuroligin 1 Proteolysis Sustains Social Memory
2026-09-11
The reference study shows that social interaction triggers α- and γ-secretase-dependent processing of Neuroligin 1 in the ventral hippocampus, generating an intracellular NLG1-CTD fragment required for social memory maintenance. Its evidence connects the fragment’s PDZ-binding domain to cofilin regulation, dendritic spine maturation, and behavioral rescue, providing a mechanistic framework for how synaptic changes persist after social learning.
-
Anagliptin (SK-0403): From Target to Tissue
2026-09-11
Anagliptin (SK-0403) is examined across two experimental scales: biochemical DPP-4 inhibition and vascular smooth-muscle physiology. This evidence-led guide explains how Kv channel and SERCA pump findings should shape assay design, controls, and interpretation.
-
2X Taq PCR Master Mix for Cassava Genotyping
2026-09-10
Streamline cassava stress-gene workflows with a ready-to-use Taq formulation that combines routine DNA amplification with direct gel loading. Its adenine-overhang chemistry also supports a practical path from genotype confirmation to TA cloning of stress-response amplicons.
-
LL-37 Truncation and Antibiofilm Selectivity
2026-09-10
Luo et al. compared the human host-defense peptide LL-37 with the truncated mimetics KE-18 and KR-12, showing that shorter sequences can improve planktonic antimicrobial activity without automatically preserving antibiofilm effects. The study’s paired crystal violet and XTT design demonstrates why biofilm biomass, metabolic activity, and microbial susceptibility should be interpreted as related but distinct endpoints.
-
AMPK Restricts ULK1 During Energy Stress
2026-09-09
The reference study challenges the prevailing view that AMPK generally activates ULK1 and autophagy during glucose starvation. Using cellular signaling, interaction, and autophagy assays, it shows that AMPK suppresses ULK1 initiation under severe energy stress while preserving the autophagy machinery for recovery after stress subsides.
-
CD38 CAR Binder Structures and Affinity Tuning
2026-09-09
Cheng et al. define how the CD38-targeting binders RP02 and 028 engage distinct antigen surfaces, alter CD38 enzymatic activity, and influence CAR-T selectivity. Their structure-guided analysis supports affinity tuning as a multidimensional design problem involving epitope geometry, catalytic inhibition, fratricide, and tumor-cell killing.
-
Ginsenoside F1 Reshapes HepG2 Lipid Metabolism
2026-09-08
A 2026 lipidomics study shows that ginsenoside F1 reduces free fatty acid-induced lipid accumulation in HepG2 cells and identifies glycerophospholipid and ether lipid metabolism as key regulated pathways. Its integrated cell assay, untargeted lipidomics, network pharmacology, and docking workflow provides a useful framework for evaluating candidate interventions in hyperlipidemia models.
-
Recombinant Annexin V for Apoptosis Detection
2026-09-08
Brumatti, Sheridan, and Martin describe a practical system for producing soluble polyhistidine-tagged annexin V in Escherichia coli, purifying it by nickel affinity chromatography, and labeling it with FITC. The resulting probe supports rapid phosphatidylserine detection by flow cytometry or fluorescence microscopy, providing a reproducible alternative to morphology-based apoptosis assessment.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-09-07
The reference study develops chemically modified p21 mRNA-loaded lipid nanoparticles for localized intravesical treatment of bladder cancer. Its data connect restoration of nuclear p21 with cell-cycle suppression, DNA-damage accumulation, apoptosis, localized bladder expression, and tumor-growth inhibition in an orthotopic model.
-
Hexamethonium Bromide in Autonomic Research
2026-09-07
Hexamethonium Bromide provides a reversible pharmacological way to test how autonomic ganglia contribute to blood pressure, baroreflex, and neuronal signaling phenotypes. Its strongest use-case is pairing acute ganglionic blockade with conscious telemetry and sex-stratified hypertension models rather than treating a blood-pressure change as a receptor-specific readout.
-
Arachidonic Acid in Translational Stroke Research
2026-09-05
A mechanistic and strategic guide to using Arachidonic Acid as a substrate-level perturbation tool in ischemia–reperfusion research, with practical guidance for linking eicosanoid biosynthesis to neuroinflammation, blood–brain barrier injury, and selective hypothermic albumin perfusion.
-
Puromycin aminonucleoside Podocyte Workflows
2026-09-04
Build reproducible podocyte injury, proteinuria, and glomerular lesion studies with a transporter-aware workflow for Puromycin aminonucleoside. This guide combines pilot dosing, morphology and filtration readouts, product handling, and a carefully bounded translation of lactylation–RNA biology from a recent pancreatic cancer study.
-
Neuroligin 1 Proteolysis in Social Memory
2026-09-04
Liu et al. show that social interaction triggers secretase-dependent Neuroligin 1 cleavage in the ventral hippocampus, producing an intracellular fragment that supports synaptic remodeling and social memory maintenance. The study provides a causal framework for connecting extracellular proteolysis, cofilin signaling, dendritic spine maturation, and the persistence of recently acquired memories.